HCPLive Network

Payment for Routine Office Visits Varies Substantially

WEDNESDAY, Sept. 18 (HealthDay News) -- There is substantial variation in private insurance payment to physicians for routine office visits, according to research published in the September issue of Health Affairs.

Laurence Baker, PhD, from Stanford University in California, and colleagues retrospectively analyzed 40 million insurance claims for routine office visits, consultations, and preventive visits in 2007, to determine variations in private payments to physicians and the extent to which these variations are explained by patients' and physicians' characteristics and by geographic region.

The researchers found much variation in payments for routine evaluation and management services, with physicians at the high end of the payment distribution being paid more than twice what physicians at the low end were paid for the same service. Patients' age or sex, physicians' specialty, place of service, whether the physician was a "network provider," or type of plan explained little variation. Approximately one-third of the variation was associated with the geographic area of the practice.

"Interventions that promote more price-consciousness on the part of patients could help reduce health care spending, but more data on the specific causes of price variation are needed to determine appropriate policy responses," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Further Reading
Among couples with an HIV-positive member, a study in the Cochrane Database of Systematic Reviews (CDSR) deemed antiretroviral therapy (ART) effective at preventing HIV transmission to the HIV-negative partner.
When a patient arrives at a hospital or other urgent care center, there are seemingly endless tests that can be undertaken to appropriately diagnose the patient. A recent study reviewed the necessity of some tests, particularly in regard to acute, nonspecific lower back pain.
Analysis of fatal cases of anaphylaxis in Canada uncovers several trends that point to a need for more effective monitoring and treatment strategies in high-risk patients.
GlaxoSmithKline's Arnuity approved for patients over the age of 12 as part of treatment options
Although ribotype 027 remains a significant cause of C. difficile infection (CDI), other strain types are gaining in prevalence, according to a study published in Antimicrobial Agents and Chemotherapy
Surgeons transplanted a kidney from a donor who had hepatitis C to a recipient who also has the disease in what is believed to be the first of its kind in the state of Utah.
Using the metric of time to first cigarette after waking (TTFC) was found to help improve efficiency and reduce false-positive detection in lung cancer screening, a new case-control study suggests.
More Reading